Jensen, J. K., Zobel, E. H., Zobel, E. H., Scholten, B. J. v., Scholten, B. J. v., Curovic, V. R., . . . Ripa, R. S. (2021). Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial. Frontiers Media S.A.
Style de citation Chicago (17e éd.)Jensen, Jacob K., et al. Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial. Frontiers Media S.A, 2021.
Style de citation MLA (8e éd.)Jensen, Jacob K., et al. Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial. Frontiers Media S.A, 2021.